Page last updated: 2024-11-03

primaquine and Neurotic Disorders

primaquine has been researched along with Neurotic Disorders in 1 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldschmidt, L1

Trials

1 trial available for primaquine and Neurotic Disorders

ArticleYear
Studies on the effect of clinical dosages of chlorpromazine and other neurotropics on primaquine-sensitive Negro mental patients.
    The Journal of nervous and mental disease, 1966, Volume: 143, Issue:1

    Topics: Adult; Anemia, Hemolytic; Black or African American; Chlorpromazine; Clinical Trials as Topic; Demen

1966